David
Jiménez Castro
Profesor/a Titular Universidad
University of Paris-Sorbonne
París, FranciaPublicacións en colaboración con investigadores/as de University of Paris-Sorbonne (23)
2024
-
Outpatient management of cancer-associated pulmonary embolism: A post-hoc analysis from the HOME-PE trial
Thrombosis Research, Vol. 235, pp. 79-87
-
Predictors of pulmonary embolism in chronic obstructive pulmonary diseases patients admitted for worsening respiratory symptoms: An individual participant data meta-analyses
European Journal of Internal Medicine
-
Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine
European Journal of Clinical Investigation
-
Safety of treating acute pulmonary embolism at home: an individual patient data meta-analysis
European Heart Journal, Vol. 45, Núm. 32, pp. 2933-2950
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Pulmonary Embolism and Chronic Obstructive Pulmonary Disease
Seminars in Thrombosis and Hemostasis, Vol. 49, Núm. 8, pp. 809-815
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
Research and Practice in Thrombosis and Haemostasis, Vol. 6, Núm. 4
-
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 857-866
2021
-
Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: The HOME-PE randomized trial
European Heart Journal, Vol. 42, Núm. 33, pp. 3146-3157
2020
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)
European Heart Journal, Vol. 41, Núm. 4, pp. 543-603
2019
-
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)
European Respiratory Journal, Vol. 54, Núm. 3
-
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
Clinical Research in Cardiology, Vol. 108, Núm. 7, pp. 772-778
2018
-
Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism
Thrombosis Research, Vol. 163, pp. 128-131
2017
-
Dabigatran after Short Heparin Anticoagulation for Acute Intermediate-Risk Pulmonary Embolism: Rationale and Design of the Single-Arm PEITHO-2 Study
Thrombosis and Haemostasis, Vol. 117, Núm. 12, pp. 2425-2434
-
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism
Journal of the American College of Cardiology, Vol. 69, Núm. 12, pp. 1536-1544
-
Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism
European Respiratory Journal, Vol. 50, Núm. 6
-
Rivaroxaban with or without aspirin in stable cardiovascular disease
New England Journal of Medicine, Vol. 377, Núm. 14, pp. 1319-1330